Drug Addiction Global Clinical Trials Review, H1, 2014
Drug Addiction Global Clinical Trials Review, H1, 2014
Summary
Glob...
alkermes Inc. (inactive) 36
clinical Trial Overview Of Alkermes Inc. (inactive) 36
sk Holdings Co., Ltd. 37
clinical Trial...
drug Addiction Therapeutics, Global, Withdrawn Clinical Trials, 2014* 26
drug Addiction Therapeutics, Global, Terminated C...
Drug Addiction Global Clinical Trials Review, H1, 2014
Upcoming SlideShare
Loading in …5
×

Research on Drug Addiction Global Clinical Trials Review, H1, 2014

419 views

Published on

Drug Addiction Global Clinical Trials Review, H1, 2014 @ http://www.researchmoz.us/drug-addiction-global-clinical-trials-review-h1-2014-report.html

This report provides elemental information and data relating to the clinical trials on Drug Addiction. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe.

Published in: Health & Medicine, Business
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
419
On SlideShare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
2
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Research on Drug Addiction Global Clinical Trials Review, H1, 2014

  1. 1. Drug Addiction Global Clinical Trials Review, H1, 2014 Drug Addiction Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, Drug Addiction Global Clinical Trials Review, H1, 2014" provides data on the Drug Addiction clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Drug Addiction. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Drug Addiction. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type - Listings of discontinued trials (suspended, withdrawn and terminated) Reasons to buy - Understand the dynamics of a particular indication in a condensed manner - Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more - Obtain discontinued trial listing for trials across the globe - Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies Table Of Contents table Of Contents 2 list Of Tables 4 list Of Figures 5 introduction 6 drug Addiction 6 report Guidance 6 clinical Trials By Region 7 clinical Trials And Average Enrollment By Country 8 top Countries Contributing To Clinical Trials In Asia-pacific 10 top Five Countries Contributing To Clinical Trials In Europe 11 top Countries Contributing To Clinical Trials In North America 12 top Countries Contributing To Clinical Trials In Middle East And Africa 13 top Countries Contributing To Clinical Trials In Central And South America 14 clinical Trials By G7 Countries: Proportion Of Drug Addiction To Central Nervous System Clinical Trials 15 clinical Trials By Phase In G7 Countries 16 clinical Trials In G7 Countries By Trial Status 17 clinical Trials By E7 Countries: Proportion Of Drug Addiction To Central Nervous System Clinical Trials 18 clinical Trials By Phase In E7 Countries 19 clinical Trials In E7 Countries By Trial Status 20 clinical Trials By Phase 21 in Progress Trials By Phase 22 clinical Trials By Trial Status 23 clinical Trials By End Point Status 24 unaccomplished Trials Of Drug Addiction 25 subjects Recruited Over A Period Of Time 28 clinical Trials By Sponsor Type 29 prominent Sponsors 30 top Companies Participating In Drug Addiction Therapeutics Clinical Trials 31 prominent Drugs 32 latest Clinical Trials News On Drug Addiction 33 may 27, 2014: Biotie: Nepicastat Study In Cocaine Dependence Completes Enrollment Ahead Of Schedule - Top-line Data Expected Around End 2014 33 clinical Trial Profiles 34 clinical Trial Overview Of Top Companies 34 rti International 34 clinical Trial Overview Of Rti International 34 johnson & Johnson 35 clinical Trial Overview Of Johnson & Johnson 35 Drug Addiction Global Clinical Trials Review, H1, 2014
  2. 2. alkermes Inc. (inactive) 36 clinical Trial Overview Of Alkermes Inc. (inactive) 36 sk Holdings Co., Ltd. 37 clinical Trial Overview Of Sk Holdings Co., Ltd. 37 reckitt Benckiser Group Plc 38 clinical Trial Overview Of Reckitt Benckiser Group Plc 38 glaxosmithkline Plc 39 clinical Trial Overview Of Glaxosmithkline Plc 39 embera Neurotherapeutics, Inc. 40 clinical Trial Overview Of Embera Neurotherapeutics, Inc. 40 catalyst Pharmaceutical Partners, Inc. 41 clinical Trial Overview Of Catalyst Pharmaceutical Partners, Inc. 41 gilead Sciences, Inc. 42 clinical Trial Overview Of Gilead Sciences, Inc. 42 d&a Pharma Sas 43 clinical Trial Overview Of D&a Pharma Sas 43 clinical Trial Overview Of Top Institutes / Government 44 national Institute On Drug Abuse 44 clinical Trial Overview Of National Institute On Drug Abuse 44 yale University 46 clinical Trial Overview Of Yale University 46 university Of Pennsylvania 47 clinical Trial Overview Of University Of Pennsylvania 47 new York State Psychiatric Institute 48 clinical Trial Overview Of New York State Psychiatric Institute 48 university Of California, Los Angeles 49 clinical Trial Overview Of University Of California, Los Angeles 49 johns Hopkins University 50 clinical Trial Overview Of Johns Hopkins University 50 medical University Of South Carolina 51 clinical Trial Overview Of Medical University Of South Carolina 51 baylor College Of Medicine 52 clinical Trial Overview Of Baylor College Of Medicine 52 university Of Arkansas 53 clinical Trial Overview Of University Of Arkansas 53 university Of Kentucky 54 clinical Trial Overview Of University Of Kentucky 54 five Key Clinical Profiles 55 appendix 74 abbreviations 74 definitions 74 research Methodology 75 secondary Research 75 about Globaldata 76 contact Us 76 disclaimer 76 source 76 list Of Tables drug Addiction Therapeutics, Global, Clinical Trials By Region, 2014* 7 drug Addiction Therapeutics, Global, Clinical Trials And Average Enrollment By Top Countries, 2014* 8 drug Addiction Therapeutics, Global, Clinical Trials In Progress By Top Countries, 2014* 9 drug Addiction Therapeutics Clinical Trials, Asia-pacific, Top Countries, 2014* 10 drug Addiction Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11 drug Addiction Therapeutics Clinical Trials, North America, Top Countries, 2014* 12 drug Addiction Therapeutics Clinical Trials, Middle East And Africa, Top Countries, 2014* 13 drug Addiction Therapeutics Clinical Trials, Central And South America, Top Countries, 2014* 14 proportion Of Drug Addiction To Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15 drug Addiction Therapeutics, G7 Countries, Clinical Trials By Phase, 2014* 16 drug Addiction Therapeutics, G7 Countries, Clinical Trials By Trial Status, 2014* 17 proportion Of Drug Addiction To Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18 drug Addiction Therapeutics, E7 Countries, Clinical Trials By Phase, 2014* 19 drug Addiction Therapeutics, E7 Countries, Clinical Trials By Trial Status, 2014* 20 drug Addiction Therapeutics, Global, Clinical Trials By Phase, 2014* 21 drug Addiction Therapeutics, Global, Clinical Trials In Progress By Phase 2014* 22 drug Addiction Therapeutics, Global, Clinical Trials By Trial Status, 2014* 23 drug Addiction Therapeutics Clinical Trials, Global, By End Point Status, 2014* 24 drug Addiction Therapeutics, Global, Suspended Clinical Trials, 2014* 25 Drug Addiction Global Clinical Trials Review, H1, 2014
  3. 3. drug Addiction Therapeutics, Global, Withdrawn Clinical Trials, 2014* 26 drug Addiction Therapeutics, Global, Terminated Clinical Trials, 2014* 27 drug Addiction Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 28 drug Addiction Therapeutics Market, Global, Clinical Trials By Sponsor Type, 2014* 29 drug Addiction Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 30 drug Addiction Therapeutics Clinical Trials, Global, Top Companies By Phase, 2014* 31 drug Addiction Therapeutics Clinical Trials, Global, Ongoing Clinical Trials By Prominent Drugs, 2014* 32 drug Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials By Rti International, 2014* 34 drug Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials By Johnson & Johnson, 2014* 35 drug Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials By Alkermes Inc. (inactive), 2014* 36 drug Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials By Sk Holdings Co., Ltd., 2014* 37 drug Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials By Reckitt Benckiser Group Plc, 2014* 38 drug Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials By Glaxosmithkline Plc, 2014* 39 drug Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials By Embera Neurotherapeutics, Inc., 2014* 40 drug Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials By Catalyst Pharmaceutical Partners, Inc., 2014* 41 drug Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials By Gilead Sciences, Inc., 2014* 42 drug Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials By D&a Pharma Sas, 2014* 43 drug Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials By National Institute On Drug Abuse, 2014* 44 drug Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials By Yale University, 2014* 46 drug Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials By University Of Pennsylvania, 2014* 47 drug Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials By New York State Psychiatric Institute, 2014* 48 drug Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials By University Of California, Los Angeles, 2014* 49 drug Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials By Johns Hopkins University, 2014* 50 drug Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials By Medical University Of South Carolina, 2014* 51 drug Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials By Baylor College Of Medicine, 2014* 52 drug Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials By University Of Arkansas, 2014* 53 drug Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials By University Of Kentucky, 2014* 54 list Of Figures drug Addiction Therapeutics, Global, Clinical Trials By Region (%), 2014* 7 drug Addiction Therapeutics, Global, Clinical Trials And Average Enrollment By Top Countries, 2014* 8 drug Addiction Therapeutics, Global, Clinical Trials In Progress By Top Countries, 2014* 9 drug Addiction Therapeutics Clinical Trials, Asia-pacific, Top Countries (%), 2014* 10 drug Addiction Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11 drug Addiction Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12 drug Addiction Therapeutics Clinical Trials, Middle East And Africa, Top Countries (%), 2014* 13 proportion Of Drug Addiction To Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15 drug Addiction Therapeutics, G7 Countries, Clinical Trials By Phase, 2014* 16 drug Addiction Therapeutics, G7 Countries, Clinical Trials By Trial Status, 2014* 17 proportion Of Drug Addiction To Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18 drug Addiction Therapeutics, E7 Countries, Clinical Trials By Phase, 2014* 19 drug Addiction Therapeutics, E7 Countries, Clinical Trials By Trial Status, 2014* 20 drug Addiction Therapeutics, Global, Clinical Trials By Phase (%), 2014* 21 drug Addiction Therapeutics, Global, Clinical Trials In Progress By Phase, 2014* 22 drug Addiction Therapeutics, Global, Clinical Trials By Trial Status, 2014* 23 drug Addiction Therapeutics Clinical Trials, Global, By End Point Status, 2014* 24 drug Addiction Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 28 drug Addiction Therapeutics Market, Global, Clinical Trials By Sponsor Type (%), 2014* 29 drug Addiction Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 30 drug Addiction Therapeutics Clinical Trials, Global, Top Companies By Phase, 2014* 31 drug Addiction Therapeutics Clinical Trials, Global, Ongoing Clinical Trials By Prominent Drugs, 2014* 32 globaldata Methodology 75 ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price. Contact: M/s Sheela, 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-997-4948 Email: sales@researchmoz.us Website: http://www.researchmoz.us/ Drug Addiction Global Clinical Trials Review, H1, 2014
  4. 4. Drug Addiction Global Clinical Trials Review, H1, 2014

×